JOHN STRAETMANS: Open Payments
NPI 1134126733 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 35 payments from 8 companies in 2025. Trend: 2023 $1,110 · 2024 $1,039 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $245 |
| ABBVIE INC. | 14 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $161 |
| Janssen Pharmaceuticals, Inc | 1 | $142 |
| Neurocrine BioSciences, Inc. | 1 | $126 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 1 | $83 |
| Lundbeck LLC | 4 | $68 |
Products named: Auvelity, VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, INGREZZA, FANAPT.
Industry payments across GA — which companies pay providers there.
